Tags:BioTechDrugInterestTechnology
A biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. (NASDAQ: NXTC)
Total raised: $160M

Investors 4

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
13.11.2018Series B$93M-vcnewsdail...
06.01.2016Series A$67M-vcnewsdail...

Mentions in press and media 10

DateTitleDescriptionCategoryAuthorSource
19.10.2021NextCure :...BELTSVILLE, Md., Oct. 19, 2021...--marketscre...
04.10.2021NextCure :...BELTSVILLE, Md., Oct. 04, 2021...--marketscre...
04.10.2021NextCure :...NextCure Announces New Appoint...--marketscre...
09.05.2019Four biote...NextCure, based in Beltsville,...--medcitynew...
13.11.2018NextCure C...-Portfolio ...-sofinnova....
13.11.2018NextCure N... BELTSVILLE, MD, NextCure tod...--vcnewsdail...
13.11.2018NextCure R...BELTSVILLE, Md.--(BUSINESS WIR...--citybizlis...
13.11.2018NextCure R...BELTSVILLE, Md.--(BUSINESS WIR...--citybizlis...
06.01.2016NextCure R...NextCure, Inc., a newly formed...USA-finsmes.co...
06.01.2016NextCure A... announced that it has raised...--vcnewsdail...